[FLT3 tyrosine kinase inhibitors: current status and future perspectives for their development].
Akinaga
Shiro
S
shiro.akinaga@kyowa.co.jp
Shiotsu
Yukimasa
Y
Kiyoi
Hitoshi
H
Naoe
Tomoki
T
D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors*
D051941:fms-Like Tyrosine Kinase 3